Cite
APA Citation
Kapp, K., Volz, B., Oswald, D., Wittig, B., Baumann, M., & Schmidt, M. (2019). beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors. Oncoimmunology, 8, . http://access.bl.uk/ark:/81055/vdc_100099954549.0x000020